| Literature DB >> 31640637 |
Mahilet Berhanu Habte1, Gurmesa Tura Debelew2, Tsedach Alemu Abebe1.
Abstract
BACKGROUND: Antiretroviral treatment (ART) has been shown to enhance the survival of people living with HIV worldwide. In Ethiopia, the number of ART users has increased from 47,422 in 2005 to 703,516 in 2017; yet, early mortality of patients has presented challenges to the success of the ART program. Because of gender roles, it is assumed that females are at risk of dying earlier after the start of the medications. Hence, this study aimed to assess the sex difference in the survival status among the ART users.Entities:
Keywords: Antiretroviral therapy; Ethiopia; Gender difference; HIV/AIDS; Survival status; Yirgalem general hospital
Mesh:
Substances:
Year: 2019 PMID: 31640637 PMCID: PMC6806493 DOI: 10.1186/s12889-019-7672-6
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Number of enrolled ART users and number of death by year among ART users of Yirgalem Hospital, Ethiopia, 2010–2015
| Year of enrolment (ART start) | Enrolled | Death/event |
|---|---|---|
| 2010–2011 | 163 | 19 |
| 2011–2012 | 138 | 15 |
| 2012–2013 | 174 | 18 |
| 2013–2014 | 128 | 12 |
| 2014–2015 | 82 | 20 |
Socio-demographic and psychosocial characteristics of ART users at the start of ART, Sep 2010 – Aug 2015, in Yirgalem General Hospital, Southern Ethiopia, Mar, 2017 (n = 685)
| Socio demographic characteristics | Female | Male | Total (%) | ||
|---|---|---|---|---|---|
| Frequency | Percent | Frequency | Percent | ||
| Age group | |||||
| 15–24 | 65 | 69.15 | 29 | 30.85 | 94 (13.72) |
| 25–34 | 210 | 64.42 | 116 | 35.58 | 326 (47.60) |
| 35–44 | 103 | 55.68 | 82 | 44.32 | 185 (27.01) |
| 45–54 | 25 | 42.37 | 34 | 57.63 | 59 (8.61) |
| > 55 | 9 | 42.86 | 12 | 57.14 | 21 (3.06) |
| Marital status | |||||
| Never married | 62 | 47.33 | 69 | 52.67 | 131 (19.12) |
| Married | 195 | 59.09 | 135 | 40.91 | 330 (48.18) |
| Divorced | 75 | 70.09 | 32 | 29.91 | 107 (15.62) |
| Widowed | 80 | 68.38 | 37 | 31.62 | 117 (17.08) |
| Level of education | |||||
| No education | 90 | 68.18 | 42 | 31.82 | 132 (19.27) |
| Primary | 154 | 63.64 | 88 | 36.36 | 242 (35.33) |
| Secondary | 124 | 57.41 | 92 | 42.59 | 216 (31.53) |
| Tertiary | 44 | 46.32 | 51 | 53.68 | 95 (13.87) |
| Occupation | |||||
| Government employed | 56 | 42.11 | 77 | 57.89 | 133 (19.42) |
| Self employed | 66 | 49.25 | 68 | 50.75 | 134 (19.56) |
| Unemployed | 244 | 78.71 | 66 | 21.29 | 310 (45.26) |
| Othera | 46 | 42.59 | 62 | 57.41 | 108 (15.77) |
| Residence | |||||
| Urban | 305 | 60.52 | 199 | 39.48 | 504 ((73.58) |
| Rural | 107 | 59.12 | 74 | 40.88 | 181 (26.42) |
| Disclosed to anyone | |||||
| Yes | 330 | 59.46 | 225 | 40.54 | 555 (81.02) |
| No | 82 | 63.08 | 48 | 36.92 | 130 (8.98) |
aStudent, daily laborer
Fig. 1Kaplan Meier survival curve of ART users, Sep 2010 –Aug 2015, in Yirgalem General Hospital, Southern Ethiopia, Mar, 2017 (n = 685)
Fig. 2Kaplan Meier survival curve showing sex difference in survival status among ART users, Sep 2010 –Aug 2015, in Yirgalem General Hospital, Southern Ethiopia, Mar, 2017 (n = 685)
Bivariate and Multivariable Cox-regression analysis of factors associated with survival status of ART users, Sep 2010 –Aug 2015, in Yirgalem General Hospital, Southern Ethiopia, Mar, 2017 (n = 685)
| Variables | Level | Death (%) | Censored (%) | Unadjusted HR (95% CI) | Adjusted HR (95%CI) |
|---|---|---|---|---|---|
| Sex | Male | 20 (7.3) | 253(92.7) | 1.00 | 1.00 |
| Female | 64 (15.5) | 348 (84.5) | 2.14(1.29, 3.54) | 1.79(1.04, 3.06) | |
| Marital status | Married | 22 (6.7) | 308(93.3) | 1.00 | 1.00 |
| Never married | 15 (11.5) | 116(88.5) | 2.03(1.05, 3.91) | 1.46(0.69, 3.04) | |
| Divorced | 23 (21.5) | 84 (78.5) | 4.03(2.24, 7.24) | 2.09(1.10, 3.97) | |
| Widowed | 24 (20.5) | 93(79.5) | 3.70(2.07, 6.60) | 1.46(0.72, 2.97) | |
| Level of education | No education | 32 (24.2) | 100(75.8) | 5.76(2.24, 14.82) | 2.54(1.29, 4.98) |
| Primary | 28 (11.6) | 214 (88.4) | 2.54(0.98, 6.57) | 2.07(1.18, 3.65) | |
| Secondary and Tertiary | 24 (5.3) | 287(94.7) | 1.00 | 1.00 | |
| Disclosure | Yes | 41 (7.4) | 514(92.6) | 1.00 | 1.00 |
| No | 43 (33.1) | 87 (66.9) | 6.75(4.37, 10.42) | 3.62(1.25, 10.46) | |
| Functional status | Working | 21 (5.3) | 373 (94.7) | 1.00 | 1.00 |
| Ambulatory | 37 (17.6) | 173(82.4) | 3.33(1.95, 5.68) | 1.74(0.92, 3.29) | |
| Bedridden | 26 (32.1) | 55 (67.9) | 7.11(3.99, 12.64) | 2.71(1.24, 5.89) | |
| TB-co infection | No TB | 32 (7.2) | 414(92.8) | 1.00 | 1.00 |
| INH prophylaxis | 12 (10.4) | 103 (89.6) | 1.61(0.83, 3.13) | 1.57(0.79 3.13) | |
| TB treatment | 40 (32.3) | 84(67.7) | 5.50(3.45, 8.77) | 2.60(1.48, 4.45) | |
| Weight | < 40 kg | 30 (26.5) | 83 (73.5) | 3.56(1.88, 6.72) | 0.76(0.37, 1.58) |
| 40-60 kg | 40 (10.1) | 357 (89.9) | 1.29(0.70, 2.37) | 0.68(0.35, 1.30) | |
| > 60 kg | 14 (8.0) | 161 (92.0) | 1.00 | 1.00 | |
| WHO stage | Stage I & II | 17(4.90) | 330(95.0) | 1.00 | 1.00 |
| Stage III | 40 (16.7) | 199(83.3) | 3.62(2.05, 6.39) | 1.53(0.74, 3.15) | |
| Stage IV | 27 (27.3) | 72 (72.7) | 7.05(3.83, 12.95) | 1.77(0.74, 4.21) | |
| CD4 count | < 200 | 57 (16.6) | 287 (83.4) | 4.10(1.48, 11.32) | 2.23(0.78, 6.35) |
| 200–350 | 23 (9.9) | 210 (90.1) | 2.30(0.79, 6.63) | 1.67(0.56, 4.96) | |
| > 350 | 4 (3.7) | 104 (96.3) | 1.00 | 1.00 | |
| Catchment | Within catchment | 50 (10.8) | 411 (89.2) | 1.00 | 1.00 |
| Outside catchment | 34 (15.2) | 190 (84.8) | 1.60(1.035, 2.48) | 1.06(0.65, 1.70) | |
| Caregiver | Yes | 40 (7.4) | 502(92.6) | 1.00 | 1.00 |
| No | 44 (30.8) | 99(69.2) | 5.99(3.88, 9.23) | 1.12(.38, 3.26) | |
| Residence | Urban | 52 (10.3) | 452 (89.7) | 1.00 | 1.00 |
| Rural | 32 (17.7) | 149(82.3) | 1.86(1.19, 2.88) | 0.68(.38, 1.21) |